Newbury Pharmaceuticals AB (publ) reported earnings results for the first quarter ended November 30, 2023. For the first quarter, the company reported sales was SEK 11.19 million compared to SEK 0.258 million a year ago. Net loss was SEK 3.52 million compared to SEK 5.74 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 SEK | +0.62% | 0.00% | +4.89% |
04-10 | Newbury Pharmaceuticals AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 | CI |
02-22 | Newbury Pharmaceuticals Secures SEK9 Million Sales Order | MT |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.89% | 7.41M | |
-12.59% | 8.23B | |
+26.58% | 1.26B | |
-13.82% | 339M | |
+0.36% | 267M | |
+8.33% | 220M | |
-45.37% | 82.2M | |
-18.35% | 78.45M | |
+26.03% | 62.1M |
- Stock Market
- Equities
- NEWBRY Stock
- News Newbury Pharmaceuticals AB
- Newbury Pharmaceuticals AB Reports Earnings Results for the First Quarter Ended November 30, 2023